Search Legislation

Commission Decision of 17 April 2008 on the allocation of quantities of controlled substances allowed for essential uses in the Community in 2008 under Regulation (EC) No 2037/2000 of the European Parliament and of the Council (notified under document number C(2008) 1403) (Only the Danish, Dutch, English, Estonian, French, German, Italian, Slovenian and Spanish texts are authentic) (Text with EEA relevance) (2008/409/EC)

 Help about what version

What Version

Close

This is a legislation item that originated from the EU

After exit day there will be three versions of this legislation to consult for different purposes. The legislation.gov.uk version is the version that applies in the UK. The EU Version currently on EUR-lex is the version that currently applies in the EU i.e you may need this if you operate a business in the EU.

The web archive version is the official version of this legislation item as it stood on exit day before being published to legislation.gov.uk and any subsequent UK changes and effects applied. The web archive also captured associated case law and other language formats from EUR-Lex.

Status:

This is the original version (as it was originally adopted).

ANNEX I

Pursuant to paragraph 3 of Decision XII/2 of the Twelfth Meeting of the Parties to the Montreal Protocol on measures to facilitate the transition to chlorofluorocarbon-free metered-dose inhalers (MDIs), the following countries have determined that, due to the presence of suitable non-CFC MDIs, CFCs no longer qualify as ‘essential’ under the Protocol when combined with following active ingredients:

LIST OF NON-ESSENTIAL SUBSTANCES

Table 1
Short-acting beta agonist bronchodilators
CountrySalbutamolTerbutalineFenoterolOrciprenalineReproterolCarbuterolHexoprenalinePirbuterolClenbuterolBitolterolProcaterol
AustriaXXXXXXXXXXX
BelgiumXXXXXXXXXXX
BulgariaXXXXXXXXXXX
CyprusXXXXXXXXXXX
Czech RepublicXXXXXXXXXXX
DenmarkXXXXXXXXXXX
EstoniaXXXXXXXXXXX
FinlandXXXXXXXXXXX
FranceXXXXXXXXXXX
GermanyXXXXXXXXXXX
GreeceXXXXXXXXXXX
HungaryXXXXXXXXXXX
IrelandXXXXXXXXXXX
ItalyXXXXXXXXXXX
LatviaXXXXXXXXXXX
LithuaniaXXXXXXXXXXX
LuxembourgXXXXXXXXXXX
MaltaXXXXXXXXXXX
NetherlandsXXXXXXXXXXX
PolandXXXXXXXXXXX
PortugalXXXXXXXXXXX
RomaniaXXXXXXXXXXX
SlovakiaXXXXXXXXXXX
SloveniaXXXXXXXXXXX
SpainXXXXXXXXXXX
SwedenXXXXXXXXXXX
United KingdomXXXXXXXXXXX
Table 2
Inhaled steroids
CountryBeclomethasoneDexamethasoneFlunisolideFluticasoneBudesonideTriamcinolone
AustriaXXXXXX
BelgiumXXXXXX
BulgariaXXXXXX
Cyprus
Czech RepublicXXXXXX
DenmarkXX
EstoniaXXXXXX
FinlandXX
FranceXX
GermanyXXXXXX
GreeceXXXXX
HungaryXXXXXX
IrelandXX
ItalyXXXXXX
LatviaXXXXXX
LithuaniaXXXXXX
LuxembourgXXXXXX
MaltaXX
NetherlandsXXXXXX
PolandXXXXXX
PortugalXXXXXX
RomaniaXXXXXX
SlovakiaXXXXXX
SloveniaXXXXXX
SpainXXX
SwedenXX
United KingdomX
Table 3
Non-steroidal anti-inflammatories
CountryCromoglicic acidNedrocromil
AustriaXX
BelgiumXX
BulgariaXX
CyprusXX
Czech RepublicXX
DenmarkXX
EstoniaXX
FinlandXX
FranceXX
GermanyXX
GreeceXX
HungaryX
Ireland
ItalyXX
LatviaXX
LithuaniaXX
LuxembourgX
MaltaX
NetherlandsXX
PolandXX
PortugalX
RomaniaXX
SlovakiaXX
SloveniaXX
SpainX
SwedenXX
United KingdomXX
Table 4
Anticholinergic bronchodilators
CountryIpratropium bromideOxitropium bromide
AustriaXX
BelgiumXX
BulgariaXX
CyprusXX
Czech RepublicXX
DenmarkXX
EstoniaXX
FinlandXX
France
GermanyXX
GreeceXX
HungaryXX
IrelandXX
Italy
LatviaXX
LithuaniaXX
LuxembourgXX
MaltaXX
NetherlandsXX
PolandXX
PortugalX
RomaniaXX
SlovakiaXX
SloveniaXX
SpainXX
SwedenXX
United KingdomXX
Table 5
Long-acting beta agonist bronchodilators
CountryFormoterolSalmeterol
AustriaXX
BelgiumXX
BulgariaXX
CyprusX
Czech RepublicXX
DenmarkX
EstoniaXX
FinlandXX
FranceXX
GermanyXX
Greece
HungaryXX
IrelandXX
ItalyXX
LatviaXX
LithuaniaXX
LuxembourgXX
MaltaXX
NetherlandsXX
PolandXX
PortugalXX
RomaniaXX
SlovakiaXX
SloveniaXX
SpainX
SwedenXX
United KingdomXX
Table 6
Combinations of active ingredients in a single MDI

Source: www.unep.org/ozone/Information_for_the_Parties/3Bi_dec12-2-3.asp

Country
AustriaX All products
BelgiumX All products
BulgariaX All products
Cyprus
Czech RepublicX All products
DenmarkX All products
Estonia
FinlandX All products
FranceX All products
GermanyX All products
GreeceX All products
HungaryX All products
Ireland
ItalyBudesonide + FenoterolFluticasone+ Salmeterol
LatviaX All products
LithuaniaX All products
LuxembourgX All products
MaltaX All products
NetherlandsX All products
PolandX All products
PortugalX All products
RomaniaX All products
SlovakiaX All products
SloveniaX All products
Spain
SwedenX All products
United Kingdom

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources